Skip to main content
. 2023 Mar 2;37(3):311–329. doi: 10.1007/s40259-023-00585-7
Adeno-associated virus (AAV) capsid, vector DNA, and transgene products induce innate and adaptive immune responses.
Several strategies such as broad immunosuppression, capsid engineering, induction of tolerance, etc. are being developed to circumvent immune-mediated toxicities associated with AAVs.